Sustainable Efficacy and Safety Results from Lummicar Study 1: A Phase 1/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma
暂无分享,去创建一个
Zonghai Li | Z. Cai | Wenming Chen | C. Fu | Yin Wu | Huamao Wang | Lingzhi Yan | Xiaolan Shi | G. Zheng | W. Gao | Wei Wang | Huijuan Wang | S. Yan | Xiaoyan Han | J. Xiao | Yanling Wen | Xiao-Yu Tang